Pure Global

Retrospective Survey of Hyperkalemia in Hemodialysis - Trial NCT05020717

Access comprehensive clinical trial information for NCT05020717 through Pure Global AI's free database. This phase not specified trial is sponsored by Peking University People's Hospital and is currently Recruiting. The study focuses on Hemodialysis Complication. Target enrollment is 300 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT05020717
Recruiting
Trial Details
ClinicalTrials.gov โ€ข NCT05020717
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Retrospective Survey of Hyperkalemia in Hemodialysis
A Multicenter Retrospective Survey of Hyperkalemia Clinical Burden on Hemodialysis Facility-level in China

Study Focus

Hemodialysis Complication

Observational

Sponsor & Location

Peking University People's Hospital

Beijing, China

Timeline & Enrollment

N/A

Sep 01, 2021

Dec 01, 2022

300 participants

Primary Outcome

To investigate the risk factors associated with hyperkalemia clinical burden on HD facility level

Summary

This study aim to describe hyperkalemia clinical burden and investigate the risk factors
 associated with the burden on HD facility level.

ICD-10 Classifications

Kidney dialysis
Other dialysis
Care involving dialysis
Mechanical complication of vascular dialysis catheter
Haemoglobinuria due to haemolysis from other external causes

Data Source

ClinicalTrials.gov

NCT05020717

Non-Device Trial